Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT00819650
Eligibility Criteria:
Inclusion Criteria:
1. Patients with HCC who received curative liver resection (R0)and with positive expression of HAb18G/CD147 in the HCC tissues
2. Karnofsky Performance Score performance over 60
3. The functions of the kidney, heart and lung and the blood system are normal and fittable for Licardin therapy.
4. The liver function is of grade A or B in Child-Pugh classification.
5. Patients give consent to the test.
Exclusion Criteria:
1. Negative expression of HAb18G/CD147 in the HCC tissues
2. Allergic history to biologic products(Licartin)
3. Any of the situation list below: WBC less than 2000/ml, Hb less than 90g/L or PLT less than 50000/ml, bilirubin level more than 2.5 times the upper limit of normal value, serum albumin less than 32 g/l.
4. Severed disease of the heart, lung, kidney, brain and blood system.
5. Other severed disease might affect the trial .
6. Patients would not sign the consent to the trial.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00819650
Study Brief:
Protocol Section:
NCT00819650